Cargando…

The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate‐risk HPV‐negative HNSCC

BACKGROUND: Only high‐risk tumors with extranodal extension (ENE) and/or positive surgical margins (PSM) benefit from adjuvant therapy (AT) with concurrent chemoradiation (CRT) compared to radiation therapy (RT) in locally advanced head and neck squamous cell carcinoma (HNSCC). Optimal treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tasoulas, Jason, Lenze, Nicholas R., Farquhar, Douglas, P. Schrank, Travis, Shen, Colette, Shazib, M. Ali, Singer, Bart, Patel, Shetal, Grilley Olson, Juneko E., Hayes, David N., Gulley, Margaret L., Chera, Bhishamjit S., Hackman, Trevor, Olshan, Andrew F., Weiss, Jared, Sheth, Siddharth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124130/ https://www.ncbi.nlm.nih.gov/pubmed/33934525 http://dx.doi.org/10.1002/cam4.3883

Ejemplares similares

Sinonasal Squamous Cell Carcinoma Survival Outcomes Following Induction Chemotherapy vs Standard of Care Therapy
por: Murr, Alexander T., et al.
Publicado: (2022)

Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer
por: Chera, Bhishamjit S., et al.
Publicado: (2020)

Correlation of alterations in the KEAP1/CUL3/NFE2L2 pathway with radiation failure in larynx squamous cell carcinoma
por: Sheth, Siddharth, et al.
Publicado: (2021)

Impact of Tumor Site and Adjuvant Radiotherapy on Survival of Patients with Adenoid Cystic Carcinoma: A SEER Database Analysis
por: Tasoulas, Jason, et al.
Publicado: (2021)

Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study
por: Falchook, Aaron D., et al.
Publicado: (2016)

Induction therapy in recurrent head and neck squamous cell carcinoma: is it time to consider response as a determinant of treatment selection?
por: Tasoulas, Jason, et al.
Publicado: (2023)

Quantifying smoking exposure, genomic correlates, and related risk of treatment failure in p16+ squamous cell carcinoma of the oropharynx
por: Schrank, Travis, et al.
Publicado: (2021)

The Impact of YRNAs on HNSCC and HPV Infection
por: Guglas, Kacper, et al.
Publicado: (2023)

Preservation of swallowing function with de-intensified chemoradiation therapy for HPV-associated oropharyngeal squamous cell carcinoma
por: Judy, Greg D., et al.
Publicado: (2018)

Impact of Oral Cavity Dosimetry on Patient Reported Xerostomia and Dysgeusia in the Setting of Deintensified Chemoradiotherapy
por: Fried, David V., et al.
Publicado: (2022)

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines
por: Busch, Chia-Jung, et al.
Publicado: (2016)

Restructuring Our Approach to Peer Review: A Critical Need to Improve the Quality and Safety of Radiation Therapy
por: Chera, Bhishamjit S., et al.
Publicado: (2020)

Cyclin A1 shows age-related expression in benign tonsils, HPV16-dependent overexpression in HNSCC and predicts lower recurrence rate in HNSCC independently of HPV16
por: Weiss, Daniel, et al.
Publicado: (2012)

Roscovitine strongly enhances the effect of olaparib on radiosensitivity for HPV neg. but not for HPV pos. HNSCC cell lines
por: Ziemann, Frank, et al.
Publicado: (2017)

Assessment of PlanIQ Feasibility DVH for head and neck treatment planning
por: Fried, David V., et al.
Publicado: (2017)

HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients
por: Rivera-Peña, Bianca, et al.
Publicado: (2016)

mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC
por: Coppock, Joseph D., et al.
Publicado: (2016)

Expressed HNSCC variants by HPV-status in a well-characterized Michigan cohort
por: Qin, Tingting, et al.
Publicado: (2018)

HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients
por: Burr, Adam R, et al.
Publicado: (2018)

CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC
por: Paulsen, Finn-Ole, et al.
Publicado: (2020)

GA-OH enhances the cytotoxicity of photon and proton radiation in HPV(+) HNSCC cells
por: Chitsike, Lennox, et al.
Publicado: (2023)

FcGBP was upregulated by HPV infection and correlated to longer survival time of HNSCC patients
por: Wang, Yating, et al.
Publicado: (2017)

Enhancer RNA Profiling in Smoking and HPV Associated HNSCC Reveals Associations to Key Oncogenes
por: Shende, Neil, et al.
Publicado: (2021)

Patient‐reported outcomes for dental health, shoulder‐neck dysfunction, and overall quality of life after treatment with radiation for head and neck cancer
por: Verma, Neha, et al.
Publicado: (2019)

CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(−) HNSCC Cell Lines
por: Trembley, Janeen H., et al.
Publicado: (2021)

Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors
por: Schrank, Travis P., et al.
Publicado: (2023)

Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line
por: Harris, Matthew, et al.
Publicado: (2011)

HPV infection related immune infiltration gene associated therapeutic strategy and clinical outcome in HNSCC
por: Zeng, Hao, et al.
Publicado: (2020)

HPV Enhances HNSCC Chemosensitization by Inhibiting SERPINB3 Expression to Disrupt the Fanconi Anemia Pathway
por: Huang, Zixian, et al.
Publicado: (2022)

Current landscape of clinical trials for HPV-positive head and neck squamous cell carcinoma (HNSCC)
por: Bteich, Yara T, et al.
Publicado: (2022)

Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC
por: Wamsley, Nathan T., et al.
Publicado: (2023)

Improved Tumor Purity Metrics in Next-generation Sequencing for Clinical Practice: The Integrated Interpretation of Neoplastic Cellularity and Sequencing Results (IINCaSe) Approach
por: Patel, Nirali M., et al.
Publicado: (2019)

Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration
por: Hu-Lieskovan, Siwen, et al.
Publicado: (2021)

Preferential Activation of the Hedgehog Pathway by Epigenetic Modulations in HPV Negative HNSCC Identified with Meta-Pathway Analysis
por: Fertig, Elana J., et al.
Publicado: (2013)

β(2)-Adrenergic receptor modulates mitochondrial metabolism and disease progression in recurrent/metastatic HPV(+) HNSCC
por: Lucido, Christopher T., et al.
Publicado: (2018)

Fewer tumour-specific PD-1(+)CD8(+) TILs in high-risk “Infiltrating” HPV(−) HNSCC
por: Xu, Ke, et al.
Publicado: (2020)

Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC
por: Gui, Shanying, et al.
Publicado: (2021)

PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival
por: Cochicho, Daniela, et al.
Publicado: (2022)

Deciphering the role of HPV-mediated metabolic regulation in shaping the tumor microenvironment and its implications for immunotherapy in HNSCC
por: Gong, Xiangjin, et al.
Publicado: (2023)

Common Error Pathways in CyberKnife™ Radiation Therapy
por: Mullins, Brandon T., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a4qvvp1502h8vqagtt911tsi72